Anitha Anne focuses on public securities offerings and general company representation of public companies. She practices corporate and securities law and represents both issuers and underwriters in capital markets transactions including initial public offerings and other equity and debt financings. Anitha also represents public life sciences and technology companies with their Securities and Exchange Commission compliance and general corporate governance matters. 

Download full bio 


  • AN2 Therapeutics – $79 Million IPO 

  • Lyell Immunopharma – $425 Million IPO 


  • University of California at Los Angeles School of Law
    JD, 2011

  • University of California, Los Angeles
    BA, Economics and Philosophy

Admissions & Credentials



Media & Insight